The global proteomics market size is valued at USD 27.82 billion in 2024 and is expected to reach USD 31.41 billion by 2025. The market is projected to grow significantly, hitting approximately USD 93.48 billion by 2034. This growth reflects a strong compound annual growth rate (CAGR) of 12.94% from 2025 to 2034.
Influential factors, such as rising developments in tailored medicine with the identification of specific protein biomarkers, along with increasing research and development activities, and the accelerating incidence of chronic diseases, cancer, cardiovascular diseases, and neurological disorders, are fueling demand for proteomics-based diagnostics and research. As well as major technological innovations, especially in mass spectrometry and bioinformatics, are majorly impacting the market growth.
Get a sneak peek into the Proteomics Market with our free sample report: https://www.towardshealthcare.com/download-sample/5680
Proteomics Market Highlights
• The proteomics sector is pushing the market to USD 27.82 billion in 2024.
• Long-term projections show a USD 93.48 billion valuation by 2034.
• Growth is expected at a steady CAGR of 12.94% between 2025 to 2034.
• North America held the largest share of 46% of the global proteomics market in 2024.
• Asia-Pacific is expected to be the fastest-growing region during 2025-2034.
• By products & services, the reagents & consumables segment dominated the market in 2024.
• By products & services, the services segment is expected to grow rapidly in the upcoming years.
• By technology, the spectrometry segment was dominant in the market in 2024.
• By technology, the next-generation sequencing (NGS) segment is expected to register a rapid expansion in the studied years.
• By application, the drug discovery segment dominated the global proteomics market in 2024.
• By application, the clinical diagnostics segment is expected to grow at the fastest CAGR during 2025-2034.
Market Overview: Upcoming Era with Technological Breakthroughs
Proteomics is a vast study of proteins, mainly their structures and functions, within a biological system. This market is experiencing major growth due to rising R&D activities in the healthcare industry, growing drug discovery and development, with accelerating demand for precision medicine. In this era, several technological advancements are arising, including single-cell proteomics, to allow the study of cellular heterogeneity and disease mechanisms, and optimized mass spectrometry techniques in proteomics with enhanced sensitivity, throughput.
Access detailed market data and key metrics with our comprehensive Proteomics databook: https://www.towardshealthcare.com/download-databook/5680
Developments in Biomarker Discovery and Personalized Medicine: Major Potential
The global proteomics market has many applications, including the development of biomarker discovery, personalized medicine, and clinical diagnostics. Particularly, in biomarker discovery, proteomics assists in identifying, validating biomarkers for different diseases like cancer, heart conditions, infectious diseases like tuberculosis and HIV, autoimmune disorders, respiratory diseases, and other diseases with enabling prior diagnosis and treatment response.
For instance,
• In June 2025, SCIEX, a global leader in life science analytical technologies, and Evosep Biosystems, a global leader in proteomics solutions, made a reseller agreement to co-sell SCIEX mass spectrometry systems with the newly announced Evosep Eno, for standardized high-throughput proteomics.
Data Complexity and High Expenditure: Major Challenges
Limitations arriving in the market are the need for high spending in advanced instruments, including mass spectrometers and high-throughput systems, along with expensive consumables like reagents and antibodies. Moreover, the generation of huge and complex datasets requires specialized software and expertise for analysis and interpretation.
The Proteomics Market: Regional Analysis
North America dominated the market in 2024, due to the raised demand for protein biomarkers with customized features to predict an individual’s response to treatment, and the vital role of proteomics in drug discovery and development to detect target and protein interaction. In this region, both public and private areas are providing investments widely in proteomics research, which is fostering breakthroughs in techniques and market expansion.
The U.S. is a major region in North America, possessing innovations in mass spectrometry, chromatography, and protein microarrays, which have increased pace, accuracy, and broad protein analysis. Along with this, the U.S. government’s encouragement with their favourable policies, funding, and initiatives is boosting R&D in proteomics is impacting the proteomic market growth.
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Latest Developments in the US
|
Organization/ Company |
Latest Updates |
|
Proteomics International Laboratories Ltd (June 2025) |
Launched its groundbreaking predictive test for diabetic kidney disease, PromarkerD, at the 85th Scientific Sessions of the American Diabetes Association (ADA) in Chicago, Illinois. |
|
Regeneron Genetics Center (June 2025) |
Unveiled proteomics study of 200k Geisinger samples using the Olink platform |
|
Illumina, Inc. (June 2025) |
Agreed with SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy |
|
Bruker Co. (June 2025) |
Launched new Timsultra AIP system with further enhanced, extreme sensitivity for single-cell proteomics, FNA biopsy immunopeptidomics, and metaproteomics. |
|
Biogen (May 2025) |
Made a strategic collaboration with City Therapeutics to develop select novel RNAi-based therapies |
|
Azenta, Inc. (May 2025) |
Partnered with GENEWIZ from Azenta Life Sciences to boost adeno-associated virus (AAV) gene therapy development through a fully integrated sequencing and data analysis solution |
In Canada, along with drug discovery and
development, demand
for personalized medicine, rising focus on biologics and biosimilars,
is further accelerating the demand for proteomics techniques. As well as
government-backed genomics initiatives and funding programs for health
innovation are majorly influencing the market growth. The Asia Pacific is Predicted to Grow
Rapidly During 2025-2034 In the proteomics market, the Asia Pacific
is anticipated to grow at the fastest CAGR in the upcoming years. With the
rising burden of chronic diseases such as cancer, diabetes, and cardiovascular
conditions, are demanding widespread advanced diagnostics and therapeutic
options, in ASAP supporting the market growth. Besides this, a robust
hub of biotechnology and the biopharmaceutical
industry in the region is also influencing the market expansion. In ASAP, India is widely recognized for its
proteomics market growth by accelerating investments in healthcare
infrastructure and research facilities. Also, nowadays, India is highly
focusing on the novel drug development with specified characteristics and based
on individuals’ information, ultimately helpful for the expansion and adoption
of healthcare predictive analytics in the development of customized
therapies. Whereas, China has significant development
in clinical diagnostics, biomarkers coupled the proteomics in major autoimmune
disorders, and the oncology sector. As well as, China has taken steps in the
advancement of single-cell and spatial proteomics, which analyze protein
expression and localization at the cellular level, and is also fueling the
overall market growth. Get the latest insights on life science
industry segmentation with our Annual Membership: https://www.towardshealthcare.com/get-an-annual-membership The Proteomics Market: Segmentation
Analysis By products & services analysis The reagents & consumables segment held
the biggest revenue share of the market in 2024. These reagents and consumables
are widely adopted in different proteomics techniques like mass spectrometry,
chromatography, electrophoresis, and microarray-based studies, along with their
incorporation in the rising drug discovery process and clinical diagnostics
development, is propelling the segment growth. However, the services segment will register
the fastest growth during the forecast period. Services, including the adoption
of well-developed technologies and specialized expertise for protein analysis,
like protein identification, quantification, and characterization, are
contributing to the segment expansion. Also, the trend of outsourcing by many
organizations for data analysis and mass spectrometry is escalating demand for
specialized services. By technology analysis The spectrometry segment dominated the
global proteomics market in 2024. Critical applications
of spectrometry are to detect proteins, find post-translational
modifications, and analyze protein-protein interactions, with its raised
advantages in drug discovery, biomarker identification, and personalized
medicine, by coupling with bioinformatics, are driving the segment growth. On the Other hand, the next-generation
sequencing (NGS) segment is estimated to grow rapidly, due to its increased
emergence in clinical diagnostics, oncology, reproductive health, and
infectious disease management are impelling the segment growth. As it is
affordable, widely adopted in research and clinical applications. By application analysis The drug discovery segment was dominant in
the global proteomics market in 2024. Proteomics is valuable in numerous
pharmaceutical industries to understand the molecular basis of diseases
and supports the development
of targeted therapies, along with these companies' major investments in
the R&D sector to develop novel molecules with the help of proteomics. Besides this, the clinical diagnostics
segment will expand rapidly during the forecast period. The segment is driven
by the use of protein-based diagnostics in the detection of disease markers in
bodily fluids like blood and urine, to foster early diagnosis and
intervention. Also, in this era, many advancements like mass spectrometry,
next-generation
sequencing, and bioinformatics for protein assays are boosting the
overall market growth. Elevate your
healthcare strategy with Towards Healthcare. Enhance efficiency and drive
better outcomes schedule a call today: https://www.towardshealthcare.com/schedule-meeting What are the Contributions of Top Market
Players in the Proteomics Market? Company Contributions & Offerings Agilent Technologies Delivers advanced LC‑MS systems (e.g., Q‑TOF, 6460 Triple Quad)
optimized for high-throughput proteomics and biomarker validation in
precision medicine. Also offers integrated bioinformatics tools and custom
proteomics services for oncology and neurology research. Alamar Biosciences Created the NULISA™ platform, combining immunocomplex capture with
next-gen sequencing to achieve attomolar sensitivity. Offers single‑plex and
multiplex protein assays via ARGO™ HT automation, delivering results in under
16 hours. Applied Biomics, Inc. Provides targeted proteomics services including high-resolution 2D
DIGE workflows, host‑cell protein profiling, and custom assay development.
Known for deep proteome coverage with field-validated analytical pipelines. Bertis, Inc. Offers proteomics consulting and custom assay support in targeted
and discovery workflows—specializing in sample prep and mass spec
bioanalysis. BOC Sciences Offers proteomics bespoke services and reagents—protein
expression, purification, assay development, and target validation for
research and drug discovery platforms. Bruker Corporation Develops advanced mass spectrometry platforms such as timsTOF
Pro/Ultra, MALDI‑TOF/ESI‑TOF, and ion‑mobility systems. Also provides spatial
proteomics imaging and collaborates in automation workflows with PreOmics. Creative Proteomics Ranks among top proteomics firms, offering protein profiling kits
for metabolic disease markers, plus standard proteomics services across
discovery to quantitation workflows. Opentrons Produces open-source liquid‑handling robots, automating proteomics
sample prep. Their OT‑2 platform enables reproducible high-throughput
workflows compatible with mass spectrometry analysis. PreOmics Provides automation and sample‑prep kits (in‑StageTip, BeatBox,
Enrichplus), enabling deep, unbiased proteomics. Time-saving workflows
(≤2.5 h prep) integrate with Bruker’s timsTOF for end-to-end pipelines. Proteome Sciences UK-based innovator in discovery proteomics services. Offers
multiplexed biomarker discovery and validation via advanced LC-MS pipelines,
serving pharma and translational research sectors.
Proteomics Market Top Companies • Agilent Technologies • Alamar Biosciences • Applied Biomics, Inc. • Bertis, Inc. • BOC Sciences • Bruker Corporation • Creative Proteomics • Opentrons • PreOmics • Proteome Sciences • Proteomics International Laboratories • Quantum-Si, Inc. • Thermo Fisher Scientific What is Going Around the Globe in the
Proteomics Market? • In June 2025, Gene Solutions, a
global multinational biotechnology company, and Shenzhen USK Bioscience
Co., Ltd., a prominent innovator in molecular diagnostics, allied to develop a
Next-Generation Sequencing laboratory in Southern China. • In May 2025, Danaher, a leading global
life sciences and diagnostics innovator, announced a partnership with
AstraZeneca to scale precision medicine, including developing the next
generation of AI-powered diagnostics. • In April 2025, Illumina Inc. and Tempus
AI, Inc., a technology company leading the adoption of AI to advance precision
medicine and patient care, collaborated to expand clinical adoption of
next-generation sequencing tests through novel evidence generation. • In February 2025, Imagene, a leader in
AI-powered Oncology Intelligence, collaborated with Tempus AI, Inc., a
technology company leading to expand AI-Driven diagnostics for non-small cell
lung cancer. • In February 2025, Opentrons, a
biotechnology company, announced a flex proteomics workstation for automated
mass spectrometry sample preparation. Proteomics Market Segmentation By Product & Services • Reagents &
Consumables • Services • Instruments By Technology • Spectrometry • Next-generation
Sequencing • Microarray
Instruments • X-Ray
Crystallography • Chromatography • Protein
Fractionation Systems • Electrophoresis • Surface Plasma
Resonance (SPR) Systems • Other
Technologies By Application • Drug Discovery • Clinical
Diagnostics • Others By Region • North America • U.S. • Canada • Asia Pacific • China • Japan • India • South Korea • Thailand • Europe • Germany • UK • France • Italy • Spain • Sweden • Denmark • Norway • Latin America • Brazil • Mexico • Argentina • Middle East
and Africa (MEA) • South Africa • UAE • Saudi Arabia • Kuwait Access the complete Proteomics Market
insights with our full ready-to-download report @ https://www.towardshealthcare.com/price/5680 Access Options: ➤
Global Deep Dive Analysis ➤
Single Regional Analysis (North America, Asia Pacific,
Europe, Latin America, Middle East and Africa) ➤
Proteomics Market Databook ➤
Cross-Sectional Analysis You can place an order or ask any
questions, please feel free to contact us at sales@towardshealthcare.com Gain access to the
latest insights and statistics in the healthcare industry by subscribing to our
Annual Membership. Stay updated on healthcare industry segmentation with
detailed reports, market trends, and expert analysis tailored to your needs.
Stay ahead of the curve with valuable resources and strategic recommendations.
Join today to unlock a wealth of knowledge and opportunities in the dynamic
world of healthcare: Get a Subscription About Us Towards
Healthcare is a leading global provider of
technological solutions, clinical research services, and advanced analytics,
with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we
build strategic partnerships that generate actionable insights and
transformative breakthroughs. As a global strategy consulting firm, we empower
life science leaders to gain a competitive edge, drive research excellence, and
accelerate sustainable growth. Our Trusted Data Partners Precedence Research | Statifacts | Towards Packaging | Towards
Automotive | Towards Food and
Beverages | Towards
Chemical and Materials | Towards Consumer
Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare Browse More Insights of Towards
Healthcare: Protein
Expression Technology Market Low-Input
Sequencing Technologies Market
